To investigate the molecular basis underlying the divergent effects of KRAS and BRAF mutations, Kundu et al. employed an integrative multi-omic approach, including transcriptomics, proteomics, and metabolomics, to investigate various isogenic KRAS or BRAF V600E mutations in RKO CRC cell lines. Here, BRAF is linked to colorectal carcinoma.